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Background: Patients with heart failure (HF) have a significant decline of renal function. Measurement of arterial stiffness is well validated in 
large population studies as strong predictor of adverse cardiovascular outcomes. In the present study we investigate the association between novel 
biomarkers of renal dysfunction and indices of arterial function in HF.
Methods: We enrolled 79 consecutive patients with HF (mean age 65) and 79 healthy subjects (Cl) adjusted for age and sex. Carotid-femoral pulse 
wave velocity (PWV) was measured as an index of aortic stiffness and augmentation index (AIx) as a measure of arterial wave reflections. Serum 
levels of Neutrophil gelatinase-associated lipocalin (NGAL), Cystatin-C, Brain natriuretic peptide (BNP) and Matrix metalloproteinase-9 (MMP-9) 
were measured by ELISA. Creatinine clearance was estimated using Cockcroft-Gault formula (eCcl).
Results: In HF patients, logCystatin-C levels was negatively correlated with eCcl (r=-0.214, p=0.049) and logNGAL levels were positively correlated 
with serum creatinine levels (r=0.458, p<0.001). Patients with HF, compared to Cl, had significantly higher PWV (9.95±2.80 m/sec vs. 9.02±1.78 
m/sec, p=0.027) and higher AIx (23.35±9.54% vs. 19.82±8.04%, p=0.047). Interestingly, in HF patients, AIx was correlated with logCystatin-C levels 
(r=0.261, p=0.029) while, PWV was correlated with logBNP levels (r=0.304, p=0.049). Furthermore, in HF patients, regression analysis revealed 
that logNGAL levels were correlated with MMP-9 levels independently of other confounders such as age, eCcl, ejection fraction, and sex [b=784 
95%CI:(314, 1253), p=0.002].
Conclusions: Elevated arterial stiffness is correlated with BNP levels in HF patients. Moreover novel biomarkers of renal function are associated 
with arterial stiffness and biomarkers of cardiac remodeling. These findings highlight a possible common pathogenetic mechanism of arterial, 
cardiac and renal dysfunction in HF.
